RxDoctor Payments Data

Sarah Taylor, NP

Family · Johnson City, TNNPI 1649696709

Payments from drug & device makers

$4,308in general payments, 2019–2025

Across 191 payments — averaging $22.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$484
  • AstraZeneca$372
  • Pfizer$243
  • Lilly USA, LLC$191
  • Johnson & Johnson$186
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$4,308100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,308 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$53,697
Medicare patients
334
Services billed
1,372

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$29,098
EliquisApixaban14$14,431
FarxigaDapagliflozin Propanediol13$11,095
Spiriva RespimatTiotropium Bromide13$8,174
Spiriva HandihalerTiotropium Bromide13$7,040
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen69$1,890
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,749
Gabapentin110$1,327
NovologInsulin Aspart12$1,249
Humalog Kwikpen U-100Insulin Lispro11$1,119
Rosuvastatin Calcium85$828
Fluticasone Propionate47$808
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav80$699
Omeprazole44$681
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst40$616

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$484$30,34742 claims
PfizerEliquis$243$14,43114 claims
AstraZenecaFarxiga$372$11,09513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Johnson City

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →